Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Hydroxychloroquine  COVID-19 treatment studies for HCQ  C19 studies: HCQ  HCQ   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
SARS-CoV-2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms
Sofian et al., Wiener Medizinische Wochenschrift, doi:10.1007/s10354-020-00793-8
Sofian et al., SARS-CoV-2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms, Wiener Medizinische Wochenschrift, doi:10.1007/s10354-020-00793-8
Dec 2020   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Report on a series of 10 patients experiencing prolonged COVID-19 symptoms that were given HCQ 250mg bid for 5 days, with resolution of symptoms in all cases, and patients reporting they felt much better 2 days after treatment initiation.
Sofian et al., 14 Dec 2020, peer-reviewed, 7 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperHCQAll
Abstract: short report Wien Med Wochenschr (2021) 171:3–6 https://doi.org/10.1007/s10354-020-00793-8 SARS-CoV-2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms Masoomeh Sofian · Ali Akbar Velayati · Mohammad Banifazl · Fatemeh Fotouhi · Mona Sadat Larijani · Neda Afzali · Amitis Ramezani Received: 19 June 2020 / Accepted: 16 November 2020 / Published online: 14 December 2020 © Springer-Verlag GmbH Austria, ein Teil von Springer Nature 2020 Summary Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as the causative agent of the ongoing pandemic, has spread into more than 200 countries to date. The disease which is caused by the virus is termed COVID-19. In most cases, it presents at first like common flu with cough and other respiratory symptoms. Nevertheless, other symptoms have been reported, such as a feeling of extreme fatigue, gastrointestinal symptoms, or acute onset of olfactory and gustatory dysfunction. Here we report a series of 10 cases (1 male, 9 females) observed between February and April 2020, with an undulating appearance and disappearance of symptoms. Weeks passed before the diagnosis was established. Symptoms resolved rapidly after treatment with hydroxyProfessor of Infectious Diseases M. Sofian Infectious Disease Research Center, Arak University of Medical Sciences, Arak, Iran Professor of Pediatrics A. A. Velayati Masih Daneshvari Hospital, Shahid Beheshti University of Medical Science, Tehran, Iran Professor of Pediatrics M. Banifazl Iranian Society for Support of Patients with Infectious Disease, Tehran, Iran Associate Professor of Virology F. Fotouhi Influenza and other Respiratory Viruses Department, Pasteur Institute of Iran, Tehran, Iran M. Sadat Larijani, PhD Clinical Research Department, Pasteur Institute of Iran, Tehran, Iran N. Afzali, Master degree of Government Management Rapid Reaction Force, Pasteur Institute of Iran, Tehran, Iran A. Ramezani, MD, PhD () Clinical Research Department, Pasteur Institute of Iran, No:69, Pasteur Ave, 1316943551 Tehran, Iran amitisramezani@hotmail.com K chloroquine. It seems that the course of COVID-19 can be mild or moderate but with a long persistence of symptoms, and may therefore remain obscure. This may cause a public health issue because of the long infectivity of these patients. Keywords COVID-19 · SARS-CoV-2 · Iran · Prolonged symptomatology · Public health
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit